Cour Pharmaceuticals Development Co Inc Known As Cour Pharmaceuticalsis A Private Biopharmaceutical Company Based In Skokieillinoisfounded In 2013The Company Specializes In Developing Innovative Nanobiological Therapeutics Aimed At Treating Acute Inflammationautoimmuneand Allergic Conditionswith A Team Of Around 66 Employeescour Pharmaceuticals Is Rooted In Research From Northwestern Universitycollaborating With Experts In Immunology And Biomedical Engineering The Company Focuses On Creating First In Class Therapies That Reprogram The Immune System To Achieve Antigen Specific Tolerance For Immune Mediated Diseasestheir Lead Productdeveloped In Partnership With Takedais Designed To Induce Immune Tolerance Specifically For Celiac Diseasecour S Unique Nanoparticle Platform Aims To Treat The Underlying Causes Of Immune Diseases While Maintaining Immune Functionalitysetting It Apart From Traditional Treatments That Often Involve Broad Immune Suppression
